Report
Mike Jeremy

FY21 results: the strategy delivers

FY21 results reflected the fruits of Mpac’s strategic initiatives, underpinned by growth in the US and the One Mpac integration process. EBITDA (adj.) grew +42%YoY to £11.2m, which was ahead of our outlook of £10.3m. Order intake crossed the £100m mark for the first time.
• An important lead indicator for future performance, Group order intake grew 41%YoY to £117.9m (FY20: £83.9m) - surpassing the £100m mark for the first time - with a closing order book of £78.4m, +41%YoY (FY20: £55.5m).
• FY21 revenue grew 13%YoY to £94.3m (ED estimate: £97.5m) led by 36%YoY growth in the Americas to £63.3m, (67% of total), and 16%YoY growth in Group Original Equipment (OE) revenue to £74.1m, 79% of total.
• EBITDA (adjusted) grew 42%YoY to £11.2m, 9% ahead of our estimate (£10.3m), with an 9.3% margin, 131bp above our outlook.
• Profit before tax (adjusted) was £8.6m, +37%YoY (H1 20: £2.8m), whilst underlying EPS (adjusted, basic) was 39.7p/share (FY20: 31.6p).
We see FY21 cashflow management as impressive given the challenging circumstances of the year, i.e. the impact of COVID-19 on demand and operating conditions, followed by the impact of the recovery from COVID-19 restrictions on supply chains and energy prices. Backed by underlying profitability and sound working capital management, including inventory build, the period-end cash balance was £14.5m, net £13.6m, compared to £11.2m in H1, net £10.3m.
Performance highlights and medium-term strategy. The contribution of strong demand from the Americas, where the US alone contributed 60% of revenue, is clear, with demand from Europe (18% of total) an additional driver to order intake. The group opened its US headquarters and showcase facility in Q3. Mpac Switchback in the US continued to trade strongly, ahead of management expectations. Cashflow management provides tangible evidence of the improvements in operational efficiency resulting from the One Mpac initiative, for example in global ERP, unified engineering, CRM and project management. This carefully-planned initiative should remain important in the light of industry-wide challenges of supply chain pressure or components and materials costs. The clean energy diversification with FREYR Battery, for prototype volume production of lithium-ion battery cells, remains on track for completion of the initial development line in Q4 22.
Outlook: continued progress in profitability and cashflow management. As a harbinger of future growth, an order book exceeding £100m underpins our outlook to FY24, albeit mindful of uncertainties arising around European security and continued pressure on energy prices. Our outlook:
• FY22E: revenue of £105.0m, +11.3%YoY, EBITDA (adj.) of £11.6m, +3.8%YoY (unchanged).
• FY23E: revenue of £112.5.0m, +7.1%YoY, EBITDA (adj.) of £12.5m, +7.3%YoY (unchanged).
• FY24E: revenue of £122.2m, +8.7%YoY, EBITDA (adj.) of £13.4m, +7.4%YoY.
Mpac aims for double-digit top line growth over the medium-term, focusing on the healthcare and food & beverage sectors – both areas of robust demand - and an EBIT profitability target of 10%. The Group continues to appraise acquisition opportunities where there is potential to broaden solutions on offer and customer base.
Our outlook places Mpac on a prospective FY23 EV/EBITDA of 8.6x and PE of 11.3x; for FY24, 8.0x and 10.6x respectively. Our fair value for Mpac shares remains 660p
Underlying
Mpac Group

Mpac Group is focused on its Packaging Machinery business, Mpac Langen, which designs, precision engineers and manufactures packaging solutions, machinery and high specification automation, secondary packaging equipment and end-of-line robotics and at-line instrumentation and testing solutions as well as providing solutions including the design and integration of packaging systems.

Provider
Equity Development
Equity Development

​Equity Development enables companies to become better understood and supported by investors. Since our launch in 1996 we have consistently focused on helping our clients improve their communication and relationships with both existing and potential shareholders. Our clients have come from a wide variety of sectors and domiciles, are both private and quoted and range in size from micro-cap to $multi-billions. We offer free access to company research notes written by experienced analysts. These notes include detailed forecasts, financial models and a fair value. We host regular Private Investor Forums at which investors have the opportunity to hear company directors present, and to ask questions. These are free to attend. We broadcast live Webinars with company management that include active Q&A. We also make the recordings available online. We arrange face to face meetings between private investors and company management. We are active users of Twitter, commenting daily on company news, share price moves, Directors’ Dealings, Equity Development Research Notes & Events.

Analysts
Mike Jeremy

Other Reports on these Companies
Other Reports from Equity Development

ResearchPool Subscriptions

Get the most out of your insights

Get in touch